Could a bladder pill save your sight? new trial tests mirabegron for dry AMD
NCT ID NCT07305298
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether mirabegron, a drug used for overactive bladder, can help people with dry age-related macular degeneration (AMD). Researchers will give 312 patients aged 50-80 either mirabegron or a standard bladder drug for 12 months and check for changes in the retina. The goal is to see if mirabegron can slow or improve the eye condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mirabegron (50 mg daily)
- What this could lead to
- If it works, this could point toward a new treatment for dry AMD using an existing drug.
- What could go wrong
- This is a small, early-stage trial with no random assignment, so results may not be conclusive. The drug is not designed for eye disease and may not improve vision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY AMD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Federico II
Naples, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Diabetes drug class may change how the bladder behaves
- Botox vs. blood plasma: which works better for a bladder that Won't quit?
- Vibrating device aims to restore bladder control in cancer survivors
- Ankle nerve zap may ease Kids' bladder troubles
- Could a Take-Home antibiotic prescription cut unnecessary ER visits after bladder botox?
- Could probiotics calm your bladder and your anxiety?